Our Services
Stem Cell Banking
Stem Cell Banking
Cord blood and cord tissue can only be collected at birth, so the decision to bank needs to be made before delivery. Cord blood transplants are an established treatment for certain blood cancers and some inherited blood, immune and metabolic disorders, and clinical trials are studying other uses. Uses of cord tissue are still being studied in clinical trials and are not yet standard treatments.
Additional Services
Free Consultation
If you are interested in learning more about our services, we offer consultations at no cost. You can call us at 416-221-1666 or visit us at our office, 701 Sheppard Avenue East, Suite 102, to learn more.
Contact UsNIPT (Non-Invasive Prenatal Testing), offered at Genaissance
Non-invasive prenatal testing (NIPT) is available from 10 weeks of pregnancy, offered at Genaissance, a genetics clinic.
Genaissance offers KNOVA by Fulgent Genetics, a prenatal cell-free DNA screening test done from a maternal blood draw as early as 10 weeks of pregnancy. It is a screening test, not a diagnostic test; a high-risk result needs follow-up diagnostic testing.
Contact UsExpanded Carrier Screening, offered at Genaissance
Genaissance offers Beacon One+ Carrier Screening by Fulgent Genetics, a pan-ethnic panel of more than 1,000 genes (1,009 genes including X-linked disorders) associated with autosomal recessive and X-linked conditions, including all 113 ACMG tier 3 genes.
Contact UsBabyDNA ID™ - Your Newborn's Lifetime Genetic Passport
For Newborns - From Day 1, Know More. - Association with Ebogenes
Discover insights into over 2,500 genes linked to childhood-onset health conditions and drug sensitivities, using a single sample from your baby’s cord blood. 47% of these findings are linked to conditions where early medical intervention can make a real difference. Focused analysis on 2,500+ clinically relevant gene. Identification of variants linked to: Inherited childhood disorders; Immune system traits; Nutrient metabolism; Adverse drug reactions and more.
Learn MoreWhat is cord blood?
Cord blood is the blood that remains in the umbilical cord and placenta after a baby is delivered. In the past, cord blood was traditionally discarded as medical waste. Today, cord blood is recognised as a source of blood-forming stem cells, and cord blood transplants are used to treat certain blood cancers and some inherited blood, immune and metabolic disorders.
Thus far, cord blood stem cells have been successfully used to treat numerous diseases, including cancers (such as leukemia, lymphomas, myelomas), blood disorders (such as thalassemias, sickle cell anemia, Fanconi’s anemia), and immune deficiency diseases. Please refer to all treatable diseases. Recently, cord blood stem cells have been used in clinical trials to repair damaged tissues and organs (regenerative medicine), and the outcomes have been promising.
What is cord tissue?
Following your baby's birth, your healthcare provider will collect a 15cm segment of the umbilical cord, known as cord tissue. This tissue, along with cord blood, can be processed using Progenics’ cord tissue collection kit. Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) are found to possess more primitive properties than adult Mesenchymal Stem Cells, exhibiting greater expansion ability and faster doubling time, making them potentially valuable for clinical use.
Cord tissue, particularly the Wharton’s Jelly portion preserved in our lab, is a rich source of Mesenchymal Stem Cells (MSCs). These cells can self-regenerate and differentiate into specialized cells like bone, cartilage, and fat cells, holding promise for regenerative medicine with reduced risk of rejection and transplant complications.
Why bank both cord blood & cord tissue?
Cord blood and cord tissue can only be collected at birth, making it a unique opportunity to preserve valuable biological resources for potential future medical use. Both offer distinct types of stem cells that support regenerative medicine, with the potential to treat a wide range of conditions.
- Cord blood contains hematopoietic (blood-forming) stem cells, which can develop into blood and immune system cells. Cord blood transplants are used to treat certain blood cancers, immune disorders and inherited metabolic disorders. Clinical trials are exploring other possible uses.
- Cord Tissue is rich in mesenchymal stem cells, which are being researched for their ability to repair damaged tissues, reduce inflammation, and support the regeneration of bone, cartilage, and muscle. Though still in clinical trials, cord tissue holds great promise for treating conditions like orthopedic injuries, heart disease, and neurological disorders. It also has regenerative potential, meaning it can be used for multiple treatments over time.
Both cord blood and cord tissue are non-invasive and painless to collect at birth. By banking both, you are securing a readily available biological resource that can be stored safely for future medical use. With ongoing advancements in regenerative medicine, the applications for both cord blood and cord tissue are expanding, offering exciting possibilities for future treatments.


